(Q40550774)

English

Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines

scientific article published on 28 May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines (English)

1 reference

Europe PubMed Central

21 September 2017

apoptotic process

0 references

author name string

Raudel Sandoval

1

1 reference

Europe PubMed Central

21 September 2017

Jiaping Xue

2

1 reference

Europe PubMed Central

21 September 2017

Mark Pilkinton

3

1 reference

Europe PubMed Central

21 September 2017

Debra Salvi

4

1 reference

Europe PubMed Central

21 September 2017

Hiroaki Kiyokawa

5

1 reference

Europe PubMed Central

21 September 2017

Oscar R Colamonici

6

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

28 May 2004

1 reference

Europe PubMed Central

21 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

21 September 2017

279

1 reference

Europe PubMed Central

21 September 2017

31

1 reference

Europe PubMed Central

21 September 2017

32275-32280

1 reference

Europe PubMed Central

21 September 2017

Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

The retinoblastoma gene: a prototypic and multifunctional tumor suppressor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Control of the cell cycle and apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Role of the retinoblastoma protein in the pathogenesis of human cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Cancer cell cycles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

p14ARF links the tumour suppressors RB and p53.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Cooperative effects of INK4a and ras in melanoma susceptibility in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Role of the INK4a locus in tumor suppression and cell mortality.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

The INK4A/ARF locus and its two gene products

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

The INK4a/ARF locus in murine tumorigenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

The tumor suppressor protein p16INK4a.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

The type I interferon receptor: structure, function, and evolution of a family business.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Recent advances in cytokines, cytokine receptors and signal transduction.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Cytokines and JAK-STAT signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Jaks and STATs: biological implications

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Biologic consequences of Stat1-independent IFN signaling.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Effects of interferon-alpha on human B cells: repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma lines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Cytokine therapeutics: lessons from interferon alpha

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

The evolution of diverse biological responses to DNA damage: insights from yeast and p53.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

The ARF/p53 pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Vanadate facilitates interferon alpha-mediated apoptosis that is dependent on the Jak/Stat pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

p19ARF links the tumour suppressor p53 to Ras

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313830200

21 January 2018

Identifiers

10.1074/JBC.M313830200

1 reference

Europe PubMed Central

21 September 2017

release_ckiqabz5knfgbh4bmyhmhgdj3a

1 reference

https://api.fatcat.wiki/v0/release/ckiqabz5knfgbh4bmyhmhgdj3a

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40550774&oldid=1900269057"